Diabetes and mental health: a Two-Year study to personalize care
NCT ID NCT05548699
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study followed 1,290 adults with type 1 or type 2 diabetes for two years. Researchers tracked mental health issues like depression, anxiety, and eating problems alongside daily blood sugar levels using smartphone surveys and continuous glucose monitors. The goal was to identify patterns and subtypes to help develop personalized treatments for mental health in diabetes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
1,290 people
The number who actually took part.
- Started
-
May 2023
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
People with Type 1 Diabetes or Type 2 Diabetes
- Ages
-
18 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age between 18 and 80 years * Diagnosis of type 1 diabetes (T1D) or type 2 diabetes (T2D) * Diabetes duration ≥ 1 year * Sufficient German language skills * Written informed consent Exclusion Criteria: * Inability to consent, * Significant cognitive impairment (e.g., cognitive disorder, dementia) * Severe somatic disease or mental disorder likely to impede study participation or confound results (e.g., severe heart failure ≥ NYHA III; cancer requiring treatment; dialysis-dependent nephropathy; schizophrenia/psychotic disorder) * Terminal illness * Being bedridden
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anxiety and fear are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Diabetes Center Mergentheim
Bad Mergentheim, Baden-Wurttemberg, 97980, Germany
-
Diabetes Practice Mergentheim
Bad Mergentheim, Baden-Wurttemberg, 97980, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Clinical and biological responses to repeated administration of low-dose Interleukin-2 in patients with type 1 diabetes and a residual insulin secretion
- Cost-Effectiveness and implementation of integrated Diabetes-Oral health care in oman: a health belief Model-Based intervention to enhance clinical, behavioral, and exploratory oral microbiome in health system outcomes in type 2 diabetes
- The dynamic mechanism of mindfulness intervention for emotional distress (MIED) based on ecological moment measurement
- Fibrinogen to albumin ratio (FAR) as a risk factor for type 2 diabetic Nephropathy(DN)
- A video Game-Style app takes on eating disorder prevention
- Can a gut supplement ease anxiety and depression in obesity?